MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
9.94
+0.20 (2.00%)
At close: Sep 17, 2025, 4:00 PM EDT
10.00
+0.06 (0.60%)
After-hours: Sep 17, 2025, 5:38 PM EDT
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $333.92 million as of September 17, 2025.
Market Cap
333.92M
Enterprise Value
109.67M
1-Year Change
n/a
Ranking
Category
Stock Price
$9.94
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has decreased from $509.66M to $333.92M, a decrease of -34.48%. That is a compound annual growth rate of -34.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 333.92M | -45.78% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |